生物标志物 生物标志物
John M Ringman1, James Luo2, Yonggand Shi3
1Department of Neurology, Keck School of Medicine at USC, Los Angeles, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
自体主导性阿尔茨海默病 (ADAD) 突变显示出不同的生物标志物模式. 根据疾病阶段,PSEN1和APP突变之间的粉样蛋白PET成像差异不同,为ADAD进展提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物研究 生物标志物研究
- 遗传学 是一个遗传学.
背景情况:
- 自体主导性阿尔茨海默氏症 (ADAD) 与晚发性阿尔茨海默氏症相比,具有神经病理学上的差异.
- 不同的ADAD突变之间存在明显的变异,需要进行特定的调查.
- 这些PSEN1 (A431E) 和APP (V717I) 突变是ADAD的关键遗传驱动因素.
研究的目的:
- 为了比较A431E PSEN1和V717I APP突变载体中的液体,MRI,PiB和FDG PET生物标志物.
- 在ADAD中分析可比临床疾病阶段的生物标志物差异.
- 为了阐明特定ADAD突变对疾病进展的影响.
主要方法:
- 利用了DIAN观察研究 (数据结15) 的数据.
- 将参与者分为无症状 (CDR=0),轻度症状 (CDR=0.5) 和痴呆 (CDR>0.5) 的组.
- 采用线性模型来比较突变载体之间的生物标志物 (血Abeta42,FDG PET,PiB PET,MRI),根据估计的年龄调整到症状发作. PiB SUVRs被标准化为体;p<0.01对于显著性.
主要成果:
- 轻微症状的A431E PSEN1载体比V717I APP载体显示出更高的血Abeta42.
- 与A431E载体相比,无症状的V717I载体在特定的大脑区域中表现出降低的大脑代谢.
- 粉样蛋白PET (PiB SUVR) 的差异因突变和疾病阶段而异,无症状,轻度症状和痴呆症携带者的区域差异显著. 没有观察到显著的CSF或MRI体积差异.
结论:
- 在粉样PET成像测量中,A431E PSEN1和V717I APP突变之间存在显著差异.
- 这些生物标志物差异取决于阶段,突出显示ADAD的不同病理轨迹.
- 这些发现强调了在ADAD研究和潜在的治疗策略中考虑特定突变类型的重要性.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511